Jing-Qiang Guo

机构：Lishui Central Hospital · ORCID：0000-0002-2061-9551

发表论文 15 篇 · 总被引 184 次 · h-index 4

代表论文

• Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE-cadherin/EphA2/MMP9/MMP2 expression (2014 · International Journal of Oncology · 被引 91)
• Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs (2015 · Molecular Medicine Reports · 被引 44)
• MicroRNA‐383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2 (2019 · Journal of Cellular and Molecular Medicine · 被引 32)
• Primary hepatic leiomyosarcoma masquerading as liver abscess: A case report (2024 · World Journal of Gastrointestinal Surgery · 被引 5)
• Identification of therapeutic targets and prognostic biomarkers of the ephrin receptor subfamily in pancreatic adenocarcinoma (2024 · Journal of International Medical Research · 被引 3)
• Impact of Nanosheet Thickness on Performance and Reliability of Polycrystalline-Silicon Thin-Film Transistors With Double-Gate Operation (2023 · IEEE Transactions on Nanotechnology · 被引 2)